TWST
Twist Bioscience CorpPress releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-05-27 |
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 27, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the |
| 2026-05-05 |
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 5, 2026-- As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 115,279 equity awards, consisting of |
| 2026-05-04 |
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
Synthesis of structurally complex and highly-engineered protein sequences to enable acceptance of approximately 99.5% of clonal gene orders and 99.9% of all DNA products Complex synthesis capabilities to support further advancement of AI-enabled drug discovery and nucleic acid therapeutics SOUTH |
| 2026-05-04 |
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--May 4, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March 31, 2026. |
| 2026-04-21 |
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
Company to host conference call at 8:00 AM ET Investor Day Scheduled for May 21, 2026 SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 21, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it will issue its financial results for |
| 2026-02-18 |
Twist Bioscience to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 18, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate |
| 2026-02-17 |
Twist Bioscience Expands Antibody Discovery Offering with Bispecific Licensing Agreement
B-Body ® platform complements Twist’s antibody discovery offering enabling rapid, efficient and precise expression and discovery of complex bispecific antibody therapeutics Platform to power high-throughput characterization of bispecific antibodies to fuel AI-enabled and traditional drug discovery |
| 2026-02-10 |
Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Twist TrueAmp Library Preparation Kit with in-house developed enzymes including new Twist TrueAmp Polymerase Twist PCR-Free WGS Library Preparation Kit designed to meet the needs of the growing whole genome sequencing market New kits compatible with additional Twist NGS Applications tools for |
| 2026-02-03 |
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 3, 2026-- As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a mid-cap growth and value biotech company, today announced that a total of 114,869 equity awards, consisting of |
| 2026-02-02 |
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025. |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-02 | William Blair 46th Annual Growth Stock Conference | Conference |
| 2026-05-21 | Twist Bioscience Investor Day 2026 | Presentation |
| 2026-05-04 | Fiscal 2026 Second Quarter Financial Results Conference Call | Conference |
| 2026-03-11 | Leerink Global Healthcare Conference | Conference |
| 2026-03-10 | Barclays 28th Annual Global Healthcare Conference | Conference |
| 2026-03-03 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-17 | Twist Bioscience Conference Call to Discuss Bispecific Licensing Agreement | Conference |
| 2026-02-02 | Fiscal 2026 First Quarter Financial Results Conference Call | Conference |
| 2026-01-12 | J.P. Morgan 2026 Healthcare Conference | Conference |
| 2025-11-17 | 7th Annual Wolfe Research Healthcare Conference | Conference |